Latest News about psychedelics
Recent news which mentions psychedelics
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
September 27, 2024
From Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
From Benzinga
Minnesota Moves Forward With Psilocybin Therapy Plan, Eyes Broader Psychedelic Reforms
September 26, 2024
Tickers
NEWS
From Benzinga
Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
September 25, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling
September 24, 2024
Tickers
NEWS
From Benzinga
Psilocybin Found To Be As Effective As Lexapro In Treating Depression, Researchers Say
September 24, 2024
From Benzinga
Nasdaq-Traded Cannabis Producer Bright Green Corporation Faces Delisting, Focuses On Strategic Growth
September 23, 2024
From Benzinga
Was Cannabis The Secret To Jesus' Healing Miracles? Study Uncovers Ancient Remedies
September 20, 2024
From Benzinga
Is Cannabis Legalization Reducing Psychiatric Drug Use? Study Reveals Interesting Trends In Benzodiazepine, Antidepressants, Antipsychotics
September 20, 2024
Tickers
NEWS
From Benzinga
Scientists Gave LSD To Autistic Dogs: Mind-Blowing Brain Changes Deepened Connections With Humans
September 20, 2024
From Benzinga
European Initiative Pushes For Psychedelic Therapy Reform To Address $669B Mental Health Problem: The Goal Is To Gather 1 Million Signatures
September 19, 2024
From Benzinga
Alabama Marijuana Company Sues Medical Cannabis Commission Over Licensing Chaos, Seeks Program Overhaul As Patients Remain In Limbo
September 19, 2024
Tickers
NEWS
From Benzinga
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
September 18, 2024
From Benzinga
Investors Back Awakn's Psychedelic Therapies, As Company Doubles Private Placement To $2M
September 18, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|